Image-guided radiation therapy Market
Image-guided radiation therapy Market Size, Share & Trends Analysis Report by Product (4D RT, LINAC, MRI-guided radiotherapy, and Portal CT Imaging), by Procedure (IMRT, Stereotactic, and Particle), by Application (Neck, Prostate, Breast, cervical, lung and other), Forecast Period (2023-2030) Update Available - Forecast 2024-2030
The global image-guided radiation therapy market is anticipated to grow at a CAGR of 6.1% during the forecast period (2023-2030). Image guided radiotherapy is a type of conformal radiotherapy which involves the use of different scans and X-rays which can treat the infected area of cancer. Conformal radiotherapy shape the radiotherapy beams around the area of the cancerous tissue. In this therapy the use of X-rays and scans similar to CT scans before and during the radiotherapy treatment. It improves the precision and accuracy of treatment delivery. These therapy are majorly used in the treatment of cancer such as neck cancer, lung cancer, cervical cancer and others.
Segmental Outlook
The global image-guided radiation therapy market is segmented on the product, procedure, and application. Based on the product, the market is sub-segmented into 4D RT, LINAC, MRI-guided radiotherapy, and Portal CT Imaging. Based on the procedure, the market is sub-segmented into IMRT, Stereotactic, and Particle. Further, on the basis of application, the market is sub-segmented into Neck, Prostate, Breast, cervical, lung and others. Among the products, the MRI-guided radiotherapy sub-segment is anticipated to hold a considerable share of the market. Magnetic Resonance Imaging Guided Linear Accelerator (MRI-LINAC) uses magnetic resonance imaging, together with radiotherapy to treat cancers throughout the body, with specific advantages for soft-tissue tumors. The radiation delivery on the MRI-LINAC is fully integrated with the MRI. Which means the system can deliver treatment radiation beams and monitor the target area at the same time. The unique combination of technologies gives our physicians greater control over the delivery of radiation because they can see the internal anatomy and tumor.
The Cervical Sub-Segment is Anticipated to Hold a Considerable Share of the Global Image-guided Radiation Therapy Market
Among the Application, the cervical cancer sub-segment is expected to hold a considerable share of the global programmatic advertisement market. The segmental growth is attributed to the growing prevalence of cervical cancer. Cervical cancer treatment has advanced dramatically over the last 20 years. Increased use of intensity-modulated radiation therapy (IMRT) and image-guided brachytherapy, in particular, have resulted in better patient outcomes and fewer treatment complications. According to an estimate of American society for radiation oncology, 13,800 American women will be diagnosed with invasive cervical cancer this year and nearly 4,300 women are expected to die from the disease. Cervical cancer can be highly treatable if detected early, however, the estimated five-year survival rate is 92 percent for early-stage disease and 56% for locally advanced disease. Cervical cancer can be highly treatable if detected early; the estimated five-year survival rate is 92 percent for early-stage disease.
Regional Outlook
The global image-guided radiation therapy market is further segmented based on geography including North America (the US, and Canada), Europe (UK, Italy, Spain, Germany, France, and the Rest of Europe), Asia-Pacific (India, China, Japan, South Korea, and Rest of Asia), and the Rest of the World (the Middle East & Africa, and Latin America). Among these, Asia-pacific is anticipated to hold a prominent share of the market across the globe, owing to the increasing number of generic population and increasing prevalence of cancer in the region.
Global Image-guided radiation therapy Market Growth, by Region 2023-2030
The North America Region is Expected to Grow at a Significant CAGR in the Global Image-guided radiation therapy Market
Among all regions, the North America regions is anticipated to grow at a considerable CAGR over the forecast period. Regional growth is attributed to increasing prevalence of cancer in the region. the American Cancer Society estimates the numbers of new cancer cases and deaths in the United States and compiles the most recent data on population-based cancer occurrence and outcomes using incidence data collected by central cancer registries and mortality data collected by the National Center for Health Statistics. In 2023, 1,958,310 new cancer cases and 609,820 cancer deaths are projected to occur in the United States.
Hence, there is considerable shift of the country towards the adoption of the image-guided radiation therapy market solutions. Radiation is an integral part of cervical cancer treatment, either following surgery for patients at risk of recurrence or as a primary definitive treatment. The regimen involves pelvic external beam radiation therapy (EBRT), often combined with chemotherapy and a brachytherapy boost.
Market Players Outlook
The major companies serving the image-guided radiation therapy market include Siemens Ag, Hitachi Ltd, Koninklijke Philips, Elekta, Viewray Technologies Inc., C-Rad, Varian Medical Systems, Toshiba Corp, and others. The market players are considerably contributing to the market growth by the adoption of various strategies including mergers and acquisitions, partnerships, collaborations, funding, and new product launches, to stay competitive in the market. For instance, in March 2022, Chonnam National University Hwasun Hospital has recently introduced the latest radiation therapy system ‘Halcyon 3.0’ and utilized it for full-scale treatment. Halcyon 3.0 is a radiation cancer treatment device which is a cutting-edge equipment that can perform intensity-modulated radiation therapy based on real-time image guidance.
The introduced ‘Halcyon 3.0’ has the advantage of delivering precise and accurate treatment up to four times faster than standard technology.
The Report Covers
- Market value data analysis of 2022 and forecast to 2030.
- Annualized market revenues ($ million) for each market segment.
- Country-wise analysis of major geographical regions.
- Key companies operating in the global image-guided radiation therapy market. Based on the availability of data, information related to new product launches, and relevant news is also available in the report.
- Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
- Analysis of market-entry and market expansion strategies.
- Competitive strategies by identifying ‘who-stands-where’ in the market.
1. Report Summary
• Current Industry Analysis and Growth Potential Outlook
1.1. Research Methods and Tools
1.2. Market Breakdown
1.2.1. By Segments
1.2.2. By Region
2. Market Overview and Insights
2.1. Scope of the Report
2.2. Analyst Insight & Current Market Trends
2.2.1. Key Findings
2.2.2. Recommendations
2.2.3. Conclusion
3. Competitive Landscape
3.1. Key Company Analysis
3.2. Altaris Capital Partners, LLC
3.2.1. Overview
3.2.2. Financial Analysis
3.2.3. SWOT Analysis
3.2.4. Recent Developments
3.3. Brainlab AG
3.3.1. Overview
3.3.2. Financial Analysis
3.3.3. SWOT Analysis
3.3.4. Recent Developments
3.4. Olympus Corp.
3.4.1. Overview
3.4.2. Financial Analysis
3.4.3. SWOT Analysis
3.4.4. Recent Developments
3.5. Key Strategy Analysis
4. Market Segmentation
4.1. Global Image-Guided Radiation Therapy Market by Product
4.1.1. 4D Radiation Therapy (Rt)
4.1.2. Medical Linear Accelerator (LINAC)
4.1.3. MRI-Guided Radiotherapy
4.1.4. Portal CT Imaging
4.2. Global Image-Guided Radiation Therapy Market by Procedure
4.2.1. Intensity-modulated radiation therapy (IMRT)
4.2.2. Stereotactic
4.2.3. Particle
4.3. Global Image-Guided Radiation Therapy Market by Application
4.3.1. Lung Cancer
4.3.2. Cervical Cancer
4.3.3. Head and Neck Cancer
4.3.4. Breast Cancer
4.3.5. Prostate Cancer
4.3.6. Others (Gynecological Cancers, Gastrointestinal Cancers, and Central Nervous System)
5. Regional Analysis
5.1. North America
5.1.1. United States
5.1.2. Canada
5.2. Europe
5.2.1. UK
5.2.2. Germany
5.2.3. Italy
5.2.4. Spain
5.2.5. France
5.2.6. Rest of Europe
5.3. Asia-Pacific
5.3.1. China
5.3.2. India
5.3.3. Japan
5.3.4. South Korea
5.3.5. Rest of Asia-Pacific
5.4. Rest of the World
6. Company Profiles
6.1. Becton, Dickinson and Co.
6.2. C-RAD
6.3. Canon Medical Systems Corp.
6.4. Elekta
6.5. GE Healthcare
6.6. Hitachi, Ltd.
6.7. IBA
6.8. Koninklijke Philips N.V.
6.9. Siemens Healthineers
6.10. Toshiba Corp.
6.11. Varian Medical Systems, Inc.
6.12. ViewRay Technologies, Inc.
6.13. Vision RT Ltd.
1. GLOBAL IMAGE-GUIDED RADIATION THERAPY MARKET RESEARCH AND ANALYSIS BY PRODUCT, 2022-2030 ($ MILLION)
2. GLOBAL 4D RT FOR IMAGE-GUIDED RADIATION THERAPY MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
3. GLOBAL LINAC FOR IMAGE-GUIDED RADIATION THERAPY MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
4. GLOBAL MRI-GUIDED RADIOTHERAPY FOR IMAGE-GUIDED RADIATION THERAPY MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
5. GLOBAL PORTAL CT IMAGING FOR IMAGE-GUIDED RADIATION THERAPY MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
6. GLOBAL IMAGE-GUIDED RADIATION THERAPY MARKET RESEARCH AND ANALYSIS BY PROCEDURE, 2022-2030 ($ MILLION)
7. GLOBAL IMAGE-GUIDED RADIATION THERAPY IN IMRT MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
8. GLOBAL IMAGE-GUIDED RADIATION THERAPY IN STEREOTACTIC MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
9. GLOBAL IMAGE-GUIDED RADIATION THERAPY IN PARTICLE MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
10. GLOBAL IMAGE-GUIDED RADIATION THERAPY MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2022-2030 ($ MILLION)
11. GLOBAL IMAGE-GUIDED RADIATION THERAPY FOR LUNG CANCER MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
12. GLOBAL IMAGE-GUIDED RADIATION THERAPY FOR CERVICAL CANCER MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
13. GLOBAL IMAGE-GUIDED RADIATION THERAPY FOR HEAD AND NECK CANCER MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
14. GLOBAL IMAGE-GUIDED RADIATION THERAPY FOR BREAST CANCER MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
15. GLOBAL IMAGE-GUIDED RADIATION THERAPY FOR PROSTATE CANCER MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
16. GLOBAL IMAGE-GUIDED RADIATION THERAPY FOR OTHER APPLICATIONS MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
17. GLOBAL IMAGE-GUIDED RADIATION THERAPY MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
18. NORTH AMERICAN IMAGE-GUIDED RADIATION THERAPY MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
19. NORTH AMERICAN IMAGE-GUIDED RADIATION THERAPY MARKET RESEARCH AND ANALYSIS BY PRODUCT, 2022-2030 ($ MILLION)
20. NORTH AMERICAN IMAGE-GUIDED RADIATION THERAPY MARKET RESEARCH AND ANALYSIS BY PROCEDURE, 2022-2030 ($ MILLION)
21. NORTH AMERICAN IMAGE-GUIDED RADIATION THERAPY MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2022-2030 ($ MILLION)
22. EUROPEAN IMAGE-GUIDED RADIATION THERAPY MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
23. EUROPEAN IMAGE-GUIDED RADIATION THERAPY MARKET RESEARCH AND ANALYSIS BY PRODUCT, 2022-2030 ($ MILLION)
24. EUROPEAN IMAGE-GUIDED RADIATION THERAPY MARKET RESEARCH AND ANALYSIS BY PROCEDURE, 2022-2030 ($ MILLION)
25. EUROPEAN IMAGE-GUIDED RADIATION THERAPY MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2022-2030 ($ MILLION)
26. ASIA- PACIFIC IMAGE-GUIDED RADIATION THERAPY MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
27. ASIA- PACIFIC IMAGE-GUIDED RADIATION THERAPY MARKET RESEARCH AND ANALYSIS BY PRODUCT, 2022-2030 ($ MILLION)
28. ASIA- PACIFIC IMAGE-GUIDED RADIATION THERAPY MARKET RESEARCH AND ANALYSIS BY PROCEDURE, 2022-2030 ($ MILLION)
29. ASIA- PACIFIC IMAGE-GUIDED RADIATION THERAPY MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2022-2030 ($ MILLION)
30. REST OF THE WORLD IMAGE-GUIDED RADIATION THERAPY MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
31. REST OF THE WORLD IMAGE-GUIDED RADIATION THERAPY MARKET RESEARCH AND ANALYSIS BY PRODUCT, 2022-2030 ($ MILLION)
32. REST OF THE WORLD IMAGE-GUIDED RADIATION THERAPY MARKET RESEARCH AND ANALYSIS BY PROCEDURE, 2022-2030 ($ MILLION)
33. REST OF THE WORLD IMAGE-GUIDED RADIATION THERAPY MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2022-2030 ($ MILLION)
1. GLOBAL IMAGE-GUIDED RADIATION THERAPY MARKET SHARE BY PRODUCT, 2022 VS 2030 (%)
2. GLOBAL 4D RT FOR IMAGE-GUIDED RADIATION THERAPY MARKET SHARE BY REGION, 2022 VS 2030 (%)
3. GLOBAL LINAC FOR IMAGE-GUIDED RADIATION THERAPY MARKET SHARE BY REGION, 2022 VS 2030 (%)
4. GLOBAL MRI-GUIDED RADIOTHERAPY FOR IMAGE-GUIDED RADIATION THERAPY MARKET SHARE BY REGION, 2022 VS 2030 (%)
5. GLOBAL PORTAL CT IMAGING FOR IMAGE-GUIDED RADIATION THERAPY MARKET SHARE BY REGION, 2022 VS 2030 (%)
6. GLOBAL IMAGE-GUIDED RADIATION THERAPY MARKET SHARE BY PROCEDURE, 2022 VS 2030 (%)
7. GLOBAL IMAGE-GUIDED RADIATION THERAPY IN IMRT MARKET SHARE BY REGION, 2022 VS 2030 (%)
8. GLOBAL IMAGE-GUIDED RADIATION THERAPY IN STEREOTACTIC MARKET SHARE BY REGION, 2022 VS 2030 (%)
9. GLOBAL IMAGE-GUIDED RADIATION THERAPY IN PARTICLE MARKET SHARE BY REGION, 2022 VS 2030 (%)
10. GLOBAL IMAGE-GUIDED RADIATION THERAPY MARKET SHARE ANALYSIS BY APPLICATION, 2022-2030 ($ MILLION)
11. GLOBAL IMAGE-GUIDED RADIATION THERAPY ON LUNG CANCER MARKET SHARE BY REGION, 2022 VS 2030 (%)
12. GLOBAL IMAGE-GUIDED RADIATION THERAPY ON CERVICAL CANCER MARKET SHARE BY REGION, 2022 VS 2030 (%)
13. GLOBAL IMAGE-GUIDED RADIATION THERAPY FOR HEAD AND NECK CANCER MARKET SHARE BY REGION, 2022 VS 2030 (%)
14. GLOBAL IMAGE-GUIDED RADIATION THERAPY FOR BREAST CANCER MARKET SHARE BY REGION, 2022 VS 2030 (%)
15. GLOBAL IMAGE-GUIDED RADIATION THERAPY FOR PROSTATE CANCER MARKET SHARE BY REGION, 2022 VS 2030 (%)
16. GLOBAL IMAGE-GUIDED RADIATION THERAPY FOR OTHERS CANCER MARKET SHARE BY REGION, 2022 VS 2030 (%)
17. GLOBAL IMAGE-GUIDED RADIATION THERAPY MARKET SHARE BY REGION, 2022 VS 2030 (%)
18. US IMAGE-GUIDED RADIATION THERAPY MARKET SIZE, 2022-2030 ($ MILLION)
19. CANADA IMAGE-GUIDED RADIATION THERAPY MARKET SIZE, 2022-2030 ($ MILLION)
20. UK IMAGE-GUIDED RADIATION THERAPY MARKET SIZE, 2022-2030 ($ MILLION)
21. FRANCE IMAGE-GUIDED RADIATION THERAPY MARKET SIZE, 2022-2030 ($ MILLION)
22. GERMANY IMAGE-GUIDED RADIATION THERAPY MARKET SIZE, 2022-2030 ($ MILLION)
23. ITALY IMAGE-GUIDED RADIATION THERAPY MARKET SIZE, 2022-2030 ($ MILLION)
24. SPAIN IMAGE-GUIDED RADIATION THERAPY MARKET SIZE, 2022-2030 ($ MILLION)
25. REST OF EUROPE IMAGE-GUIDED RADIATION THERAPY MARKET SIZE, 2022-2030 ($ MILLION)
26. INDIA IMAGE-GUIDED RADIATION THERAPY MARKET SIZE, 2022-2030 ($ MILLION)
27. CHINA IMAGE-GUIDED RADIATION THERAPY MARKET SIZE, 2022-2030 ($ MILLION)
28. JAPAN IMAGE-GUIDED RADIATION THERAPY MARKET SIZE, 2022-2030 ($ MILLION)
29. SOUTH KOREA IMAGE-GUIDED RADIATION THERAPY MARKET SIZE, 2022-2030 ($ MILLION)
30. REST OF ASIA-PACIFIC IMAGE-GUIDED RADIATION THERAPY MARKET SIZE, 2022-2030 ($ MILLION)
31. REST OF THE WORLD IMAGE-GUIDED RADIATION THERAPY MARKET SIZE, 2022-2030 ($ MILLION)
